NiketaCShahMD

Chief, Pediatric Stem Cell Transplant and Cellular Therapy Physician Rutgers Cancer Institute of New Jersey

Dr. Shah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
195 Little Albany St
Ste 2900
New Brunswick, NJ 08901
Phone+1 732-235-2465

Fax+1 732-235-8234

Memorial Sloan Kettering Cancer CenterFellowship, Pediatric Stem Cell Transplant, 2009 - 2010
Rutgers Health/Newark Beth Israel Medical CenterResidency, Pediatrics, 2006 - 2009
Hospital for Sick ChildrenPediatric Hematology Oncology Fellowship, 2003 - 2006
Gujarat Cancer and Research InstitutePediatric Hematology Oncology, 1997 - 2003
Sheth KM School of Post Graduate Medicine and ResearchMD, Pediatric Residency , 1994 - 1997
N.H.L Municipal Medical CollegeClass of 1994

PubMed

33 citations
Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease
Alexander Ngwube, Niketa Shah, Kamar Godder, David A. Jacobsohn, Monica L. Hulbert
Blood Advances. 2020-08-25
4 citations
Incidence and risk factors of pain crisis after hematopoietic cell transplantation for sickle cell disease.
Lakshmanan Krishnamurti, Jingchen Liang, Zili He, Yanhong Deng, Vineetha R Nallagatla
Blood Advances. 2024-04-23
14 citations
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
Rohtesh S. Mehta, Shernan G. Holtan, Tao Wang, Michael T. Hemmer, Stephen R. Spellman
Blood Advances. 2019-05-14

Abstracts/Posters

Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease
Niketa C. Shah, MD , Sweta Bhoopatiraju , Allistair Abraham, MD , Eric Jon Anderson, MD , Martin Andreansky, MD , Monica Bhatia, MD , Sonali Chaudhury, MD , Geoff D.E...., American Society of Hematology, Virtual, 12/5/2020
Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL
Niketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)
Niketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019